G1 多能性与癌症的交叉路口中的动态
Dalia Fleifel1, Jeanette Gowen Cook1
1Department of Biochemistry & Biophysics, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Cancers
|September 28, 2023
概括
干细胞和癌细胞在G1细胞周期动态上具有相似之处,受SOX2和OCT4等多能性因子的调节. 了解这些联系为多能性和瘤产生提供了洞察力.
科学领域:
- 细胞生物学 细胞生物学
- 发展生物学 发展生物学
- 癌症生物学 癌症生物学
背景情况:
- G1细胞周期阶段动力学由复杂的循环素,循环素依赖激酶 (CDK) 和CDK抑制剂网络控制.
- 在G1期间适当的原产地许可对于DNA复制和保持基因组完整性至关重要.
- 多能性因子 (SOX2,OCT4,KLF4,c-MYC) 是干细胞多能性的关键,并且在癌细胞中经常异常表达.
研究的目的:
- 审查和比较干细胞与癌细胞中的G1动态.
- 探索这些动态的监管机制和功能结果.
- 研究多能性因子在两种细胞类型G1调节中的作用.
主要方法:
- 关于干细胞和癌细胞生物学近期进展的文献综述.
- 对管理G1阶段进展的监管网络的分析.
- 对多能因子表达和功能的比较研究.
主要成果:
- 在干细胞和癌细胞之间的G1动态中存在显著的平行和差异.
- 多能性因子在干细胞和癌细胞的G1动态中起着调节作用.
- 多能性因子的异常表达影响癌症中的细胞周期控制.
结论:
- 多能性因子和G1动态之间的相互作用是理解瘤发生的关键领域.
- 对干细胞G1调节的洞察力可能有助于癌症研究.
- 对这些联系的进一步研究可能会揭示新的治疗点.
相关概念视频
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Cells Coordinate Growth and Proliferation
4.5K
Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
4.5K
Cancer
48.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.7K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


